Award recordCONTRACT

ACTELION PHARMACEUTICALS US, INC.

PIID 36C26018N0040· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6505 · DRUGS AND BIOLOGICALS· FY2018· $153,562 net obligations· UEI H5BMHLMMNA28· CA

Description

DRUGS: UPTRAVI (SELEXIPAG)TITRATION SIZE 200MCG 66215-0602-14, UPTRAVI (SELEXIPAG) 800MCG 66215-0608-06, UPTRAVI (SELEXIPAG) TITRATION COMBO (200MCG AND 800MCG) 66215-0628-20

First action · last action
2017-10-19 · 2019-12-11
Transactions
3
First transaction's obligation
$141,201
Base + all options value (sum of deltas)
$153,562
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
VA797P16A0015
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$162,872$0Base award · 2017-10-19 · this action $141,201 · running total $141,201Modification P00001 · 2018-06-06 · this action $21,670 · running total $162,872Modification P00002 · 2019-12-11 · this action -$9,309 · running total $153,562
  • Base2017-10-19+$141,201= $141,201
  • Mod P000012018-06-06+$21,670= $162,872
  • Mod P000022019-12-11-$9,309= $153,562
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2017-10-19+$141,201$141,201DRUGS: UPTRAVI (SELEXIPAG)TITRATION SIZE 200MCG 66215-0602-14, UPTRAVI (SELEXIPAG) 800MCG 66215-0608-06, UPTRA…
Mod P00001· FUNDING ONLY ACTION2018-06-06+$21,670$162,872DRUGS: UPTRAVI (SELEXIPAG)TITRATION SIZE 200MCG 66215-0602-14, UPTRAVI (SELEXIPAG) 800MCG 66215-0608-06, UPTRA…
Mod P00002· FUNDING ONLY ACTION2019-12-11−$9,309$153,562DRUGS: UPTRAVI (SELEXIPAG)TITRATION SIZE 200MCG 66215-0602-14, UPTRAVI (SELEXIPAG) 800MCG 66215-0608-06, UPTRA…

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI H5BMHLMMNA28)

AwardOffice · PSC / listingNet obligationsFY
36C24526N0477245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$47,052FY2026
36C24526N0181245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$22,235FY2026
36C26026F0024260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$65,500FY2026
36C26026F0017260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$406,538FY2026
36C26025F0209260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$197,168FY2025
36C26025F0107260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$70,630FY2025

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26026F0379COSETTE PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$3,466FY2026
36C26026P0671MCKESSON PLASMA AND BIOLOGICS LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$18,262FY2026
36C26026F0349AGIOS PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$73,080FY2026
36C26026F0306BRACCO DIAGNOSTICS INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$337,422FY2026
36C26026F0298PROGENICS PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$469,134FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26018N0040_3600_VA797P16A0015_3600 · retrieved 2026-09-26.